SLC6A8 and Brain atrophy: However, the fact that patients with defects in the SLC6A8 gene experience progressive brain atrophy, cognitive disability and speech deficit, which cannot be treated by creatine oral supplementation, indicate an essential role of Crt1 in maintaining optimal brain creatine levels.